PMC:7600245 / 23547-23689 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T221","span":{"begin":64,"end":69},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"}],"text":" than lopinavir/ritonavir with INF-α [73]. Furthermore, an open-label, prospective, randomized, multicenter study in adults (n = 236) with COV"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T321","span":{"begin":6,"end":25},"obj":"Chemical"},{"id":"T322","span":{"begin":6,"end":15},"obj":"Chemical"},{"id":"T323","span":{"begin":16,"end":25},"obj":"Chemical"},{"id":"T324","span":{"begin":31,"end":34},"obj":"Chemical"},{"id":"T325","span":{"begin":64,"end":69},"obj":"Chemical"}],"attributes":[{"id":"A321","pred":"chebi_id","subj":"T321","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A322","pred":"chebi_id","subj":"T322","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A323","pred":"chebi_id","subj":"T323","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A324","pred":"chebi_id","subj":"T324","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"},{"id":"A325","pred":"chebi_id","subj":"T325","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"}],"text":" than lopinavir/ritonavir with INF-α [73]. Furthermore, an open-label, prospective, randomized, multicenter study in adults (n = 236) with COV"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"639","span":{"begin":31,"end":36},"obj":"Gene"},{"id":"652","span":{"begin":6,"end":25},"obj":"Chemical"}],"attributes":[{"id":"A639","pred":"tao:has_database_id","subj":"639","obj":"Gene:3451"},{"id":"A652","pred":"tao:has_database_id","subj":"652","obj":"MESH:C558899"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" than lopinavir/ritonavir with INF-α [73]. Furthermore, an open-label, prospective, randomized, multicenter study in adults (n = 236) with COV"}